Combination therapy for visceral leishmaniasis
Top Cited Papers
- 1 March 2010
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 10 (3) , 184-194
- https://doi.org/10.1016/s1473-3099(10)70011-6
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Paromomycin in the treatment of leishmaniasisExpert Opinion on Investigational Drugs, 2008
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?Nature Reviews Microbiology, 2007
- Miltefosine – discovery of the antileishmanial activity of phospholipid derivativesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral LeishmaniasisClinical Infectious Diseases, 2006
- Chemotherapy in the Treatment and Control of LeishmaniasisAdvances in Parasitology, 2006
- Development of Miltefosine for the LeishmaniasesMini-Reviews in Medicinal Chemistry, 2006
- Focus: LeishmaniasisNature Reviews Microbiology, 2004
- Leishmaniasis: current situation and new perspectivesComparative Immunology, Microbiology and Infectious Diseases, 2004
- Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agendaThe Lancet Infectious Diseases, 2002
- LeishmaniasisThe Lancet, 1999